Aster DM Quality Care Ltd.

Combined Proforma Revenue: ₹2,597 crore
Combined Proforma Operating EBITDA: ₹576 crore

Reader Takeaway: Strong proforma growth post-merger, but watch for final audit adjustments.

What just happened

Aster DM Quality Care Ltd. has announced its financial results for the first quarter of fiscal year 2027 (Q1 FY27) on a combined proforma basis. This reporting follows the company's merger, which became effective on July 1, 2026.

The company reported a combined proforma revenue of ₹2,597 crore for the quarter, representing a significant 20% increase compared to the same period in the previous fiscal year.

Operating EBITDA also saw a substantial jump of 30% year-on-year, reaching ₹576 crore. This growth led to an expansion in operating EBITDA margins to 22.2%.

Why this matters

These results offer the first glimpse into the combined entity's financial performance after the merger. The strong year-on-year growth in both revenue and operating profit suggests positive operational synergy and market reception post-integration.

The company's Return on Capital Employed (ROCE) stood at a healthy 22.9%.

The backstory

The reporting is on a combined proforma basis, indicating that the figures are presented as if the merger had occurred prior to the start of the reporting period. This allows for a more meaningful comparison of the combined entity's performance.

What changes now

This is the initial reporting for the merged entity, providing a baseline for future performance. The company has a stated objective to expand its bed capacity to 15,000 beds in the coming years.

Risks to watch

Management has cautioned that these proforma numbers are indicative. They are subject to final audit adjustments and reconciliation of accounting policies between the merged entities. Investors should await the audited consolidated financial statements for definitive figures.

Segment Performance

In Q1 FY27, the Aster DM Healthcare segment reported revenue of ₹1,311 crore and operating EBITDA of ₹279 crore, with a margin of 21.7% (excluding Kasaragod). The Quality Care segment posted revenue of ₹1,287 crore and operating EBITDA of ₹299 crore, achieving a margin of 23.2%.

Investor Takeaway

The combined proforma results for Aster DM Quality Care in Q1 FY27 signal a promising start post-merger with robust growth in revenue and operating profits. The management's focus on expanding bed capacity to 15,000 beds highlights future growth ambitions. Investors should closely monitor the integration progress and the upcoming audited results to confirm these performance indicators.